These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16649336)

  • 1. Therapeutic drug monitoring--its highs and lows (peaks and troughs).
    Nardini JM
    Nephrol Nurs J; 2000 Dec; 27(6):561-2. PubMed ID: 16649336
    [No Abstract]   [Full Text] [Related]  

  • 2. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():403-5. PubMed ID: 15658349
    [No Abstract]   [Full Text] [Related]  

  • 5. The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.
    Sharma R; Guy M; Rudenski A; Lamerton E; Kalra PA
    QJM; 2009 Oct; 102(10):747-50. PubMed ID: 19602599
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug dosing in older patients with chronic kidney disease.
    Perrin E
    Am Fam Physician; 2007 Dec; 76(12):1766. PubMed ID: 18217516
    [No Abstract]   [Full Text] [Related]  

  • 7. [A form for soliciting the measurement of drug plasma level and its use in a university hospital].
    Espinoza E; Kramer V; Saavedra H; Biagini L
    Rev Med Chil; 1991 Nov; 119(11):1284-90. PubMed ID: 9723081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practice of digoxin therapeutic drug monitoring.
    Barclay M; Begg E
    N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY; Singh H
    Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest in therapeutic drug monitoring of the main antibiotics].
    Davani S; Muret P; Royer B; Hoen B; Kantelip JP
    Ann Biol Clin (Paris); 2002; 60(6):655-61. PubMed ID: 12446229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dosage methods for drug compounds in chronic kidney failure].
    Siniukhin VN; Darenkov AF; Klimova TZ
    Sov Med; 1988; (6):115-7. PubMed ID: 3187663
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of antibacterial agents in renal failure.
    Livornese LL; Slavin D; Gilbert B; Robbins P; Santoro J
    Infect Dis Clin North Am; 2004 Sep; 18(3):551-79, viii-ix. PubMed ID: 15308276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
    Fitzpatrick F; McGaley T; Rajan L; Crowley R; Turley M; Humphreys H; Smyth E
    J Clin Pathol; 2006 Jun; 59(6):666-7. PubMed ID: 16731612
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory assays in renal failure: therapeutic drug monitoring.
    Fissell WH
    Semin Dial; 2014; 27(6):614-7. PubMed ID: 24995571
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drugs: uses and effects. Anticoagulants.
    Lake R; Jordan S
    Nurs Stand; 2005 Jan 19-25; 19(19):suppl 1-2. PubMed ID: 15812975
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved pharmacokinetic monitoring of tacrolimus exposure after pediatric renal transplantation.
    Lee MN; Butani L
    Pediatr Transplant; 2007 Jun; 11(4):388-93. PubMed ID: 17493218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dried blood spot measurement of tacrolimus is promising for patient monitoring.
    Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L
    Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges.
    Christians U; Schmitz V; Schöning W; Bendrick-Peart J; Klawitter J; Haschke M; Klawitter J
    Ther Drug Monit; 2008 Apr; 30(2):151-8. PubMed ID: 18367974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus.
    French DC; Saltzgueber M; Hicks DR; Cowper AL; Holt DW
    Clin Chem; 2001; 47(7):1316-9. PubMed ID: 11427469
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of oxytetracycline in biological matrix.
    Kowalski C; Pomorska M; Lebkowska B; Sławik T
    Acta Pol Pharm; 2006; 63(5):409-11. PubMed ID: 17357597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.